That Patient with Neck Pain in Exam Rm 2 May not Need a Neurology Referral Today
The patient with neck pain might be better off referred to a physiatrist for additional evaluation and possibly treatment, according to PM&R physician Atul Patel, MD.
Empagliflozin Wins FDA Approval for the Treatment of Adults with CKD
Empagliflozin is approved to lower the risk of sustained decline in eGFR, end-stage kidney disease, CV death, and hospitalization in adults with CKD at risk of progression.
Daily Dose: Antihypertensive Treatment Throughout Late Life Lowers Risk of Dementia
Your daily dose of the clinical news you may have missed.
Waist-to-Hip Ratio More Consistently Associated with Mortality vs BMI: New Research
Waist-to-hip ratio was more powerfully and consistently associated with risk of all-cause mortality than BMI or FMI, but can it replace BMI as a clinical indicator?
Abbott, WeightWatchers Announce App Integrating FreeStyle Libre 2 CGM Data
The new app is designed to help persons with diabetes understand how food and activity impact blood glucose levels and to revise behavior accordingly.
Mental Health in the US: Happiest States in 2023
What state has highest share of adult depression? Or the lowest divorce rate? Find the answers and more insights from a nationwide analysis, here.
Daily Dose: Risky Alcohol Use Among US Adults Prescribed Alcohol-Interactive Medications
Long-COVID Rehabilitation Interventions Improve Symptoms but Research on Safety Still Needed
Meta-analysis: Among persons with symptoms of long COVID, respiratory and exercise training were effective but pooled information on safety was "uncertain, imprecise."
A PM&R Generalist May be Just What Primary Care Needs: New Interview
A member of the board of the American Academy of Physical Medicine & Rehabilitation highlights the breadth of his practice.
For Episodic Migraine, Both OTC and New Oral Prescription Medications Provide Meaningful Pain Relief
In episodic migraine, both traditional oral OTC medications and newly approved classes led to significantly better improvements in pain compared with placebo.
Fatigue Common in Migraine, More Severe in Chronic vs Episodic Disease
Fatigue was positively correlated with frequency, duration, severity and chronicity of migraine episodes and more common among chronic migraineurs, a new study reveals.
Early Initiation of Childhood Obesity Treatment Linked to Better Weight Outcomes Over Time
An intensive parent-support early childhood obesity intervention program led to better weight status outcomes in the long-term compared to standard therapy, report study authors.
Daily Dose: Parental Stigma Toward HPV Vaccine Barrier to Adolescent Uptake
USPSTF Publishes Final Guidance on Screening for Hypertensive Disorders of Pregnancy
The USPSTF recommends that BP be checked at all prenatal visits for all pregnant persons and calls for reducing vast inequities in maternal health care.
Antiobesity Medications: Expert Compares Benefits, Drawback Among Classes
Obesity specialist Sandra Christensen, MSN, ARNP, compares the benefits and drawbacks among older antiobesity drugs and newer GLP-1RAs liraglutide and semaglutide 2.4 mg.
Daily Dose: Efficacy of a Remote Bilingual Program in Reducing Uncontrolled HTN
Novel Factor XI Inhibitor Abelacimab Found Superior to Rivaroxaban in Phase 2b Trial with High-Risk Cohort
The AZALEA-TIMI 71 trial was stopped early due to an "overwhelming reduction" in a composite endpoint of major bleeding events compared to rivaroxaban standard of care.
Why is Wound Care Falling to Primary Care?
Overscheduled and undertrained, primary care clinicians shoulder a significant portion of the US wound care burden. Author Nima Ahmadi offers a technology-based solution.
Antihypertensive Treatment Throughout Late Life May Reduce Risk of Dementia
Results from a new study show that older adults with untreated hypertension had a 42% increased risk of dementia vs healthy controls.
FDA Accepts Resmetirom NDA, Grants Priority Review, and Sets PDUFA Date
Resmetirom, a once-daily oral, thyroid hormone receptor (THR)-β selective agonist, targets key underlying NASH pathophysiology in the liver.
